Patient Recruitment and Site Selection

North America remains one of the fastest growing regions for biotech-sponsored trials and there is a growing interest from US biotechs to expand their clinical development here. While there are many benefits in running clinical trials in North America, sponsors can often face fragmented markets and heterogeneous regulatory pathways.

Greenline Clinical Research relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites and investigators for your study.

• Oncology CRO services, and Immuno-Oncology CRO services
• Infectious diseases and Vaccines CRO services
• Orphan and Rare diseases CRO services

Regional advantages

North America region is a preferred location for clinical studies because of lower trial density, large pools of patients, high number of active investigators, with efficient regulatory pathways.

Greenline Clinical Research has partnered with some of the leading medical institutions in the region. The Partnership Program is strategically designed to bring unparalleled access to quality investigators, key opinion leaders, and patients for its international biotech clients.

From our management

“We've enjoyed exceptionally strong growth. But we remain very focused on our core mission, of being a full-service CRO, specializing in biotech sector sponsors conducting trials in the North America region. The provinces in our Country are very different, and a core part of our job is to match sponsor needs to country characteristics.”